Skip to main content
Equibles
ENDV logo

ENDV · Endonovo Therapeutics, Inc. · Earnings Call Transcripts & Audio

Track ENDV — free

Use ENDV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ENDV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 At close · Sep 16
Rebalance outlook locked
Going-concern doubt — flagged Dec 29, 2023

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt as to its ability to continue as going concern within one year from issuance date of these unaudited consolidated financial statements.”
View the 10-Q filed Dec 29, 2023
Market Cap
$31,875
Shares
318.75M

Endonovo Therapeutics, Inc. Earnings Call Transcripts

Quarterly earnings calls for Endonovo Therapeutics, Inc. (ENDV), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

No Earnings Calls Available

No earnings call events are available for this stock yet.

Key facts CIK 1528172 Visit website